Vaxcyte, Inc. (PCVX)
54.10
-0.85
(-1.55%)
USD |
NASDAQ |
Feb 13, 16:00
54.11
+0.01
(+0.02%)
After-Hours: 20:00
Vaxcyte Market Cap : 7.082B for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 156.81B |
| Novavax, Inc. | 1.414B |
| Moderna, Inc. | 16.50B |
| Rhythm Pharmaceuticals, Inc. | 6.545B |
| Sutro Biopharma, Inc. | 137.67M |
Market Cap Related Metrics
| PEG Ratio | -2.108 |
| Price to Book Value | 2.448 |
| Price | 54.10 |
| Earnings Yield | -9.10% |
| PEGY Ratio | -2.108 |